Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Search Results 21-30 of 72 for Oral
Daclatasvir plus sofosbuvir Daclatasvir plus sofosbuvir is an all-oral, once-daily regimen for difficult-to-treat genotype 3.
CT angiography (CTA) without oral contrast is recommended for urgent imaging in patients with active bleeding, especially those with hemodynamic instability.
Tofacitinib Approved in 2018, tofacitinib is a selective Janus kinase (JAK) inhibitor and the first oral medication approved for treatment of moderate to severe ulcerative colitis.
Direct oral anticoagulants (DOACs) are increasingly used, and as a whole, they are more effective than warfarin in stroke prevention with a lower risk of intracerebral hemorrhage.
For more information Oral EA, et al.
In these circumstances, alternative forms of oral anxiolysis or monitored (deeper) anesthesia in the operating room may be needed.
In this trial, a small molecule (oral agent) inhibitor of the receptor for activated complement factor 5, avacopan, is being compared head-to-head with standard glucocorticoid dosing for remission induction.
Risk factors for ONJ include: Invasive dental procedures Poor oral hygiene Prolonged anti-resorptive therapy Dr.
While the use of oral aminosalicylates and corticosteroids can be effective in suppressing the inflammatory process and inducing symptomatic remission, this approach has not been shown to alter the natural history of IBD, reduce inci...
Related Content Article The gaining popularity of oral appliances Article Getting to the heart of sleep Article Home sleep apnea test simplifies diagnosing obstructive sleep apnea
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.